lucanthone hydrochloride has been researched along with HIV in 1 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 1 (100.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Bagaya, BS; Boggild, AK; Galiwango, RM; Good, SV; Joag, V; Kaul, R; Kiwanuka, N; Mpendo, J; Tannich, E; Yegorov, S | 1 |
1 trial(s) available for lucanthone hydrochloride and HIV
Article | Year |
---|---|
Schistosoma mansoni treatment reduces HIV entry into cervical CD4+ T cells and induces IFN-I pathways.
Topics: Adult; Animals; CD4-Positive T-Lymphocytes; Cells, Cultured; Cervix Uteri; Disease Susceptibility; Female; HIV; HIV Infections; Humans; Interferon-alpha; Praziquantel; Primary Cell Culture; Schistosoma mansoni; Schistosomiasis mansoni; Schistosomicides; Signal Transduction; Uganda; Up-Regulation; Vaginal Smears; Virus Internalization; Young Adult | 2019 |